Search

everythinglearnresearchcommunity

for

Search:↓

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

The multi-injection plate is a less painful and more efficient method for treating patchy hair loss.

A lotion with natural extracts significantly sped up hair growth in women with hair loss from chemotherapy.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Laser treatment for skin conditions VEN and ILVEN is effective and liked by patients.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Baricitinib helps treat severe hair loss in people over 65.

Biological therapy boosts the immune system to effectively fight melanoma.

Tofacitinib might be used to treat hair loss.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

A 12-year-old boy had severe shingles and skin damage after a stem-cell transplant.

A skin condition called pyodermatitis vegetans was found in a patient with multiple myeloma for the first time.

lncRNA VIM-AS1 helps heal diabetic wounds by boosting energy production and reducing cell aging.

Clofazimine successfully treated a man's ashy dermatosis, clearing his skin lesions.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

GC10/DOX hydrogel shows promise as an effective thyroid cancer treatment.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

SVF is safe and effective, but research quality is low; new guidelines are proposed to improve future studies.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

Rapid virilization should be checked for possible ovarian or adrenal cancer.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

A young woman with a rare fungal infection showed significant improvement after treatment with antifungal medication.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.